iTeos Therapeutics, Inc. (DELISTED) (ITOS:DL)
10.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 05, 16:00
iTeos Therapeutics Shareholders Equity (Quarterly): 493.80M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ZimVie, Inc. (DELISTED) | 412.80M |
| Sarepta Therapeutics, Inc. | 1.320B |
| Black Titan Corp. | 1.985M |
| Solid Biosciences, Inc. | 217.95M |
| Replimune Group, Inc. | 263.34M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 623.08M |
| Total Liabilities (Quarterly) | 129.28M |
| Debt to Equity Ratio | 0.0104 |
| Current Ratio | 7.528 |
| Net Debt Paydown Yield | 0.03% |